Clinical Overview
Flurazepam is a long-acting benzodiazepine indicated for the treatment of insomnia characterized by difficulty falling asleep, frequent nocturnal awakenings, and early morning awakening. It provides effective sleep induction and maintenance but carries risks associated with long-acting benzodiazepines, particularly in elderly patients.
Primary Clinical Applications
Flurazepam is indicated for insomnia management, particularly when both sleep onset and sleep maintenance are problematic. Its long half-life makes it suitable for patients with frequent nighttime awakenings but increases the risk of next-day sedation and accumulation with repeated dosing.
Mechanism and Clinical Benefits
Flurazepam enhances GABA neurotransmission by binding to benzodiazepine receptors, producing sedative, anxiolytic, and muscle relaxant effects. Its active metabolites have very long half-lives (40-114 hours), providing sustained sleep benefits but also prolonged effects.
Special Considerations
The long duration of action requires careful consideration in elderly patients and those with hepatic impairment. Tolerance and dependence can develop with prolonged use, and withdrawal symptoms may occur upon discontinuation. The medication should be used for short-term treatment only.
Prescribing Information
Dosing & Administration
Insomnia – Adults:
- Usual dose: 30 mg at bedtime
- Alternative: 15 mg may suffice in some patients
Elderly/Debilitated:
- Initial: 15 mg at bedtime
- Rationale: Increased sensitivity and slower elimination
Administration:
- Take immediately before bedtime
- Ensure 7-8 hours available for sleep
- Avoid alcohol and other CNS depressants
Indications
- Insomnia characterized by difficulty falling asleep
- Frequent nocturnal awakenings
- Early morning awakening
- Short-term use only (7-10 days)
Contraindications
- Known hypersensitivity to flurazepam or other benzodiazepines
- Sleep apnea syndrome
- Severe respiratory insufficiency
- Myasthenia gravis
- Acute narrow-angle glaucoma
Warnings & Precautions
- Complex sleep behaviors: Sleep-driving, sleep-eating, other activities
- CNS depression: Risk of oversedation, especially in elderly
- Respiratory depression: Caution in pulmonary disease
- Dependence and withdrawal: Risk with prolonged use
- Next-day impairment: Due to long half-life of metabolites
- Falls risk: Particularly in elderly patients
Drug Interactions
- CNS depressants: Enhanced sedation and respiratory depression
- Alcohol: Dangerous potentiation of effects
- Opioids: Increased risk of respiratory depression
- CYP3A4 inhibitors: May increase flurazepam levels
Adverse Reactions
Common:
- Drowsiness, dizziness, lightheadedness, ataxia
Next-Day Effects:
- Residual sedation, impaired coordination, confusion
Serious:
- Complex sleep behaviors, respiratory depression, falls
Special Populations
- Elderly: Lower starting dose due to increased sensitivity
- Hepatic impairment: Prolonged elimination, use with caution
- Pregnancy: Category X – contraindicated
- Renal impairment: Use with caution, monitor for accumulation
Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.
